Arkin Bio Multi-Stage
Partners in Biotech Innovation

A leading global life sciences VC with funds focused on early-stage biotech through Arkin Bio Ventures and late-stage biotech via Arkin Bio Capital. With strong scientific expertise, industry insights, and a vast network of collaborators, we nurture promising life science companies worldwide.

Proven Biotech
Investment Expertise

Arkin Bio leads investments alongside top global partners, driving robust growth and impactful advancements. Our team has a strong background in biopharmaceuticals, drug development, business development, and management, with a proven track record.

2010

Founded In
4 Funds

Arkin Bio Ventures I, Arkin Bio Ventures II, Arkin Bio Ventures III, Arkin Bio Capital
Investment Stages

Arkin Bio Ventures backs early-stage, pre-clinical, and clinical-stage biotech companies | Arkin Bio Capital invests in clinical-stage biotechs, financing the clinical proof of concept

M&A

M&A

IPO

Connecting Research to Opportunities

Our expansive ecosystem enables us to tap into cutting-edge research and clinical expertise, enhancing our ability to identify and support groundbreaking ventures. Arkin Bio is committed to nurturing promising opportunities and ensuring the success of each investment.

Relationships That Resonate: Words from Our Partners

“We have worked closely with Arkin Bio from the Series A in 2016 through the IPO in April 2020. Alon showed a great balance between realizing the potential and the risks of the technology. He helped nurture the early programs through thoughtful discussions and ensuring that the company was appropriately capitalized to optimize the opportunity.”

Jasbir S. Seehra

CEO and Chairman at Keros Therapeutics

“During these challenging times to raise capital, we have been blessed to find Arkin. They led our recent round, and Pini is a true partner with me in working with the syndicate, understanding our technology, and helping to guide our development. I highly recommend Arkin to any startup looking for a no-nonsense, honest, and diligent investor.”

Rick Batycky

CEO at Nocion Therapeutics

“Arkin Bio has supported Auron since they led our seed financing in 2020. Their conviction to back groundbreaking science and their business expertise have been instrumental to Auron’s success. They work together with their CEO’s and Alon has been a true partner and mentor to me. His unwavering commitment has fueled our progress every step of the way. “

Kate Yen

Founder and CEO at Auron Therapeutics

“Since 2016, we've worked closely with Arkin Bio as our sole investor. Their team has been instrumental in driving our success, providing invaluable professional expertise and support. Their commitment and understanding of our mission make them exceptional partners in every sense.”

Jonathan Reis

Former Founder, President & CEO, and Member of the Board of Directors at Censa Pharmaceuticals

01 / 04